MedPage Today on MSN
Case Study: Encouraging Treatment for Patient With Advanced HR+/HER2- Breast Cancer With Visceral Crisis
Endocrine therapy is generally recommended for patients with HR+/HER2-metastatic breast cancer, with the exception of those ...
Medpage Today on MSN
Common Everyday Meds Linked to Worse Outcomes in Breast Cancer Patients
The use of proton pump inhibitors with anti-cancer therapies was associated with worse survival outcomes in patients with breast cancer. Concomitant use of proton pump inhibitors and other everyday ...
Exercise can help women with advanced breast cancer better withstand both cancer treatments and the ravages of the disease, a ...
Doctors have already begun reducing radiation treatment for women at low risk of recurrence or spread of the disease. A new ...
Program Leader Erik Nelson's lab made an important discovery about the relationship between cholesterol and breast cancer ...
OVER 28TH STREET. A SALISBURY WOMAN AND WAKE FOREST UNIVERSITY GRADUATE HAS CREATED A PRODUCT TO HELP BREAST CANCER PATIENTS RECOVER POST SURGERY. AFTER SEEING HER MOTHER GO THROUGH A DIFFICULT BATTLE ...
Plastic surgeon working to modernize the Women's Health and Cancer Rights Act gets some unexpected support from Grey's ...
People with HER2+/HR+ advanced breast cancer had the longest survival times — 42 months on average at the start and 53 months ...
Patritumab deruxtecan shows meaningful clinical activity in heavily pretreated patients with metastatic breast cancer and ...
AlohaCare members, including those enrolled in Medicaid and Medicare, will have more access to medical equipment like breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results